POET Technologies (NASDAQ: POET) staged a sharp rebound on Friday, with shares climbing approximately 11% to $12.53, far outpacing the broader semiconductor sector. The rally came amid renewed enthusiasm for AI-driven photonics, but the stock remains under the shadow of significant legal and financial risks that could shape its trajectory in the weeks ahead.
The company, which designs photonic integrated circuits and optical modules for AI and data-center markets, saw heavy trading volume of over 34 million shares during Friday's session. By comparison, the Invesco QQQ Trust rose just 0.6% and the iShares Semiconductor ETF gained 1.5%, underscoring the outsized volatility in POET shares.
Capital Raise and Dilution Concerns
On May 18, POET closed a non-brokered registered direct offering with a single institutional investor, issuing approximately 19 million common shares along with warrants to purchase an equal number of shares. The deal raised gross proceeds of $400 million. While the fresh capital provides a cushion for expansion, it also introduces significant dilution risk for existing shareholders. The warrants, exercisable at a future date, could further dilute equity if converted.
CEO Dr. Suresh Venkatesan stated that the company is "expanding our capacity by roughly ten-fold" in wafer production and optical-engine assembly, tied to the Lumilens agreement and other opportunities. However, the company's financials remain modest: first-quarter 2026 revenue was just $503,389, with a net loss of $12.3 million, or $0.08 per share.
Legal Risks Intensify
A securities class action lawsuit continues to weigh on investor sentiment. The Rosen Law Firm issued a reminder on June 13 of the June 29 lead-plaintiff deadline for purchasers of POET securities between April 1, 2026 and April 27, 2026. The lawsuit alleges misstatements regarding the company's possible PFIC (Passive Foreign Investment Company) status and disclosures around business agreements. These remain claims and have not been adjudicated.
Adding to the legal overhang, Faruqi & Faruqi highlighted on June 12 that the complaint references the cancellation of purchase orders from Celestial AI (now owned by Marvell), after Marvell allegedly cited unauthorized disclosures of confidential order and shipping details. This history explains why POET stock can fall sharply on disclosure concerns, even amid strong AI-photonics demand.
Catalysts Ahead
The next major event is POET's annual meeting on June 26, 2026, where shareholders may receive updates on governance, the planned U.S. domicile shift, and manufacturing expansion. The company has stated its intention to move its headquarters and domicile to the U.S. to mitigate future PFIC classification risk. Following that, the June 29 lead-plaintiff deadline in the class action could drive further volatility.
Additionally, any concrete updates on Lumilens engineering samples or production readiness could serve as a catalyst. The company has a $50 million purchase order framework with Lumilens, but execution remains key.
For now, POET shares appear best suited for investors with a high risk tolerance who are watching for evidence that the company can convert its technology and purchase orders into repeatable, high-volume revenue. The bull case includes a large capital raise and a compelling AI photonics narrative, but the bear case is equally material: tiny revenue, significant losses, dilution, and unresolved legal issues.
